Continue to site >
Trending ETFs

10+ Year-increasing Pharmaceutical Stock Reaffirmed in Best Dividend Protection Stocks Model Portfolio

Innovation remains the mantra for the healthcare sector these days as advanced drugs and devices continue to drive results and profits at the major healthcare stocks. This includes our latest Best Dividend Protection Stocks Model Portfolio pick, which has been rewarding shareholders with over 10 years’ worth of dividend growth. Investors can catch the firm’s 3.1% yield when it goes ex-dividend on Wednesday, September 14, 2022, with a regular payout of $0.69 per share.

Our pick has long been one of the largest pharmaceutical stocks, with a history of big blockbusters under its belt. But in recent years, it has made the move into a biotech machine. After plowing plenty of big bucks into advanced research, our pick now has an oncology portfolio that produces ample cash flow.

And it’s using that cash flow smartly. M&A and research continues to fill out its pipeline, while excess cash has gone back into buybacks and dividend growth.

The combination of future revenues, cash flow today and stability makes the stock an ideal selection for conservative investors.

You can check out the Best Dividend Protection Stocks Model Portfolio to explore all the stocks.

Get Premium to keep reading
This is a premium article. Please sign up for Premium to access this article and other Premium content.
Learn more